-2146826259
ENP Newswire 2011, Oct 28
-
- 2,99 €
-
- 2,99 €
Beschreibung des Verlags
ENPNewswire-October 28, 2011--Boehringer Ingelheim implements additional guidance supporting appropriate use of Pradaxa (dabigatran etexilate) in Europe(C)2011 ENPublishing - http://www.enpublishing.co.uk ENP Newswire - 28 October 2011
GENRE
Business und Finanzen
ERSCHIENEN
2011
28. Oktober
SPRACHE
EN
Englisch
UMFANG
7
Seiten
VERLAG
Normans Media Ltd.
ANBIETERINFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
GRÖSSE
72,6
kB
Solnyx Pharmaceuticals: The Atoxeril Clinical Trial
2005
Novartis Receives FDA Approval of Tekamlo, A Single-Pill Combination of Aliskiren and Amlodipine to Treat High Blood Pressure
2010
A Three-Step Approach to Conversion of Prevalent Catheter-Dependent Hemodialysis Patients to Arteriovenous Access.
2011
Conversion from Epoetin Alfa to Darbepoetin Alfa Within the Manitoba Renal Program: Evaluation of Dose Ratios.
2008
Agennix AG Gets Positive Results from Talactoferrin Trial
2010
Treatment of Neuropathic Pain in Patients with Chronic Kidney Disease (Continuing EDUCATION Series) (Report)
2011
-2146826259
2011
-Ferrum Crescent Limited - Quarterly Activities and Cashflow Report for the Period Ended 30 September 2011
2011
-Nyota Minerals Limited - Quarterly Report to 30 September 2011
2011
-2146826259
2011
-2146826259
2011
-Venoco, Inc. Announces Third Quarter 2011 Financial and Operational Results
2011